Short interest in Herbalife Ltd. (NYSE:HLF) was riding high even before the company reported third quarter earnings that missed expectations. As of the end of Q3, 33% of Herbalife’s shares were out on loan, compared to a 25% short interest reported at the end of second quarter.
Herbalife among top ten most shorted
According to Goldman Sachs’ Hedge Fund Trend Monitor, a quarterly report, Herbalife Ltd. (NYSE:HLF) is once again among the top ten most shorted stocks. Following Bill Ackman’s public short attack in December 2012, Herbalife almost doubled, making it a painful short call. However, now the stock that caused clashes among hedge fund titans has dropped back to a much humbler share price. The nutrition supplements company lowered guidance for the current fiscal year and next year in the latest earnings call. Herbalife also showed much lower sales growth than was expected. The new compliance framework that the company recently adopted is taking toll on growth and has triggered multiple falls in share price over the year. The decline has hurt long holders of the company, including Carl Icahn, Perry Corp and Soros Fund. On the short side, what was once an almost ‘exclusive’ Bill Ackman short seems to have attracted other funds. It is possible that a large percentage of the float is no longer held by Pershing Square as Ackman has restructured his short bet.
Transocean short interest leaps to 22%
A dramatic change in short interest took place at Transocean LTD (NYSE:RIG) as well, shooting up to 22% of equity cap from 15% in the previous quarter. Fewer rig contracts have made for a difficult environment for the oil and gas driller. Here again, Icahn is holding a huge chunk of shares, 21 million shares. Transocean has fallen nearly 50% this year so far.
Post Holdings and Cliff Natural reward shortsellers
Tech companies face heat from shortsellers
Short interest reduces in Mallinckrodt
Stocks where short interest fell significantly include Mallinckrodt PLC (NYSE:MNK) which recently completed the acquisition of Questcor Pharmaceuticals Inc (NASDAQ:QCOR). Short interest is now at 11%, compared to 27% at the end of second quarter. Mallinckrodt, a specialized pharmaceuticals company, now has 24% of its equity cap owned by hedge funds,down from 91% at the end of June quarter.